Skip to main content
Log in

Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies

  • Review
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background

Systemic chronic inflammation has been proposed as an essential mediating factor in frailty, and several studies tested its relationship with frailty. However, the issue is still controversial.

Objectives

We identified observational studies and pooled their results to assess whether abnormal expression of inflammatory biomarkers is present in the blood of older adults with frailty.

Methods

We conducted a systematic search on the Medline, Embase, and Web of Science database from inception to 1st September 2021. The quality of included studies was assessed using the JBI Critical Appraisal Checklist for Analytical Cross-Sectional Studies (JBI-MAStARI). Study heterogeneity was assessed with the Cochran Q test and I2 statistic. Pooled estimates were obtained through random-effect models. Sensitivity analyses were conducted by excluding one of the studies. Egger’s regression test and observation of funnel plots were used to detect small-study effects and publication bias. PROSPERO registration: CRD42020172853.

Result

A total of 53 cross-sectional studies corresponding to 56 independent study populations were included in this analysis. There were 31 study populations with three frailty categories (3144 frailty, 14,023 pre-frailty, 10,989 robust) and 25 study populations with two frailty categories (2576 frailty, 8368 non-frailty). This meta-analysis performed pooled analyses for the inflammatory biomarker leukocyte, lymphocytes, CRP, IL-6, IL-10, and TNF-α. Older adults with frailty had lower lymphocytes and higher interleukin-6 (IL-6), C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α) levels compared with the control group. However, there was no significant difference in leukocyte and IL-10 levels in the two groups.

Conclusions

These findings suggest that peripheral inflammatory biomarkers lymphocytes, IL-6, CRP, and TNF-α are related to frailty status. Our findings are not conclusive regarding the causal relationship between chronic inflammation and frailty, so the development of further longitudinal and well-designed studies focused on this is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and materials

All data generated or analyzed during this study are included in this published article and its supplementary information files.

References

  1. Morley JE et al (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14:392–397

    Article  PubMed  PubMed Central  Google Scholar 

  2. Pansarasa O et al (2019) Altered immune system in frailty: genetics and diet may influence inflammation. Ageing Res Rev 54:100935

    Article  PubMed  Google Scholar 

  3. Hoogendijk EO et al (2019) Frailty: implications for clinical practice and public health. Lancet 394:1365–1375

    Article  PubMed  Google Scholar 

  4. Xu W, Li YX, Wu C (2019) Incidence of frailty among community-dwelling older adults: a nationally representative profile in China. BMC Geriatr 19:378

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15:505–522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sherifali D (2019) Diabetes and frailty: revisiting the converging conditions. Can J Diabetes 43:81

    Article  PubMed  Google Scholar 

  7. Wilson D et al (2017) Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev 36:1–10

    Article  PubMed  Google Scholar 

  8. Vatic M, von Haehling S, Ebner N (2020) Inflammatory biomarkers of frailty. Exp Gerontol 133:110858

    Article  PubMed  Google Scholar 

  9. Li H, Manwani B, Leng SX (2011) Frailty, inflammation, and immunity. Aging Dis 2:466–473

    PubMed  PubMed Central  Google Scholar 

  10. Soysal P et al (2016) Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev 31:1–8

    Article  CAS  PubMed  Google Scholar 

  11. Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1

    Article  PubMed  PubMed Central  Google Scholar 

  12. Luo D et al (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27:1785–1805

    Article  PubMed  Google Scholar 

  13. Peters M et al (2016) The Joanna Briggs Institute reviewers' manual 2015: methodology for JBI scoping reviews

  14. McKechnie DGJ et al (2021) Associations between inflammation, cardiovascular biomarkers and incident frailty: the British Regional Heart Study. Age Ageing. https://doi.org/10.1093/ageing/afab143

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pillatt AP et al (2021) Muscle, endocrine, and immunological markers of frailty in older people. Exp Gerontol 151:111405

    Article  PubMed  Google Scholar 

  16. Rizka A et al (2021) Immunomodulatory effect of in vitro calcitriol in fit and frail elderly. Int Immunopharmacol 96:107737

    Article  CAS  PubMed  Google Scholar 

  17. Serviddio G, Romano AD, Greco A et al (2009) Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress. Int J Immunopathol Pharmacol 22:819–827

    Article  CAS  PubMed  Google Scholar 

  18. Qu T et al (2009) Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine 46:319–324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Almeida OP et al (2012) CRP 1846G>A polymorphism increases risk of frailty. Maturitas 71:261–266

    Article  CAS  PubMed  Google Scholar 

  20. Gale CR et al (2013) Inflammatory markers and incident frailty in men and women: the English Longitudinal Study of Ageing. Age (Dordr) 35:2493–2501

    Article  CAS  Google Scholar 

  21. Arts MH et al (2015) Relationship between physical frailty and low-grade inflammation in late-life depression. J Am Geriatr Soc 63:1652–1657

    Article  PubMed  Google Scholar 

  22. Chao CT et al (2015) Simple self-report FRAIL scale might be more closely associated with dialysis complications than other frailty screening instruments in rural chronic dialysis patients. Nephrology (Carlton) 20:321–328

    Article  Google Scholar 

  23. Singer JP et al (2015) Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med 192:1325–1334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Mansur HN et al (2015) Association of frailty with endothelial dysfunction and its possible impact on negative outcomes in Brazilian predialysis patients with chronic kidney disease. BMC Nephrol 16:157

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Tay L, Lim W, Chan M et al (2016) The independent role of inflammation in physical frailty among older adults with mild cognitive impairment and mild-to-moderate Alzheimer’s disease. J Nutr Health Aging 20:288–299

    Article  CAS  PubMed  Google Scholar 

  26. Margolick JB et al (2017) Frailty and circulating markers of inflammation in HIV+ and HIV- men in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 74:407–417

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ma L et al (2018) Elevated serum IL-6 and adiponectin levels are associated with frailty and physical function in Chinese older adults. Clin Interv Aging 13:2013–2020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Valdiglesias V et al (2018) Immunological alterations in frail older adults: a cross sectional study. Exp Gerontol 112:119–126

    Article  CAS  PubMed  Google Scholar 

  29. Yang Y et al (2018) Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 and C-reactive protein among older Chinese hospitalized patients. Aging Clin Exp Res 30:1459–1464

    Article  PubMed  Google Scholar 

  30. Rusanova I et al (2018) Analysis of plasma MicroRNAs as predictors and biomarkers of aging and frailty in humans. Oxid Med Cell Longev 2018:7671850

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Semmarath W et al (2019) The association between frailty indicators and blood-based biomarkers in early-old community dwellers of Thailand. Int J Environ Res Public Health 16:3457

    Article  CAS  PubMed Central  Google Scholar 

  32. Palmer J et al (2019) The acute inflammatory response after trauma is heightened by frailty: A prospective evaluation of inflammatory and endocrine system alterations in frailty. J Trauma Acute Care Surg 87:54–60

    Article  CAS  PubMed  Google Scholar 

  33. Hammami S et al (2020) Evaluation of pro-inflammatory cytokines in frail Tunisian older adults. PLoS ONE 15:e0242152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Santos Morais Junior G et al (2020) Circulating interleukin-6 (but not other immune mediators) associates with criteria for fried’s frailty among very old adults. J Aging Res 2020:6831791

    Article  PubMed  PubMed Central  Google Scholar 

  35. Xu L, Zhang J, Shen S et al (2021) Clinical frailty scale and biomarkers for assessing frailty in elder inpatients in China. J Nutr Health Aging 25:77–83

    Article  CAS  PubMed  Google Scholar 

  36. Hubbard RE et al (2009) Inflammation and frailty measures in older people. J Cell Mol Med 13:3103–3109

    Article  PubMed  PubMed Central  Google Scholar 

  37. Wu IC et al (2009) High oxidative stress is correlated with frailty in elderly chinese. J Am Geriatr Soc 57:1666–1671

    Article  PubMed  Google Scholar 

  38. Leng SX et al (2011) IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageing 40:475–481

    Article  PubMed  PubMed Central  Google Scholar 

  39. Carcaillon L et al (2012) Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the toledo study for healthy aging. J Clin Endocrinol Metab 97:2898–2906

    Article  CAS  PubMed  Google Scholar 

  40. Kalyani RR, Varadhan R, Weiss CO et al (2012) Frailty status and altered dynamics of circulating energy metabolism hormones after oral glucose in older women. J Nutr Health Aging 16:679–686

    Article  CAS  PubMed  Google Scholar 

  41. Darvin K et al (2014) Plasma protein biomarkers of the geriatric syndrome of frailty. J Gerontol A Biol Sci Med Sci 69:182–186

    Article  CAS  PubMed  Google Scholar 

  42. Fontana L et al (2013) Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients. Aging Cell 12:459–466

    Article  CAS  PubMed  Google Scholar 

  43. Hwang AC et al (2015) Association of frailty and cardiometabolic risk among community-dwelling middle-aged and older people: results from the I-lan longitudinal aging study. Rejuvenation Res 18:564–572

    Article  CAS  PubMed  Google Scholar 

  44. Piggott DA et al (2015) Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use. J Gerontol A Biol Sci Med Sci 70:1542–1547

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Saum KU et al (2015) Association between oxidative stress and frailty in an elderly German population: results from the ESTHER cohort study. Gerontology 61:407–415

    Article  CAS  PubMed  Google Scholar 

  46. Liu CK et al (2016) Biomarkers of oxidative stress are associated with frailty: the Framingham Offspring Study. Age (Dordr) 38:1

    Article  CAS  Google Scholar 

  47. Armstrong JJ et al (2010) Examining three frailty conceptualizations in their ability to predict negative outcomes for home-care clients. Age Ageing 39:755–758

    Article  PubMed  Google Scholar 

  48. Lee WJ et al (2016) Soluble ICAM-1, independent of IL-6, is associated with prevalent frailty in community-dwelling elderly Taiwanese people. PLoS ONE 11:e0157877

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Lu Y, Tze C, Nyunt MS et al (2016) Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studies. Oncotarget 17:28783–28795

    Article  Google Scholar 

  50. Van Epps P et al (2016) Frailty has a stronger association with inflammation than age in older veterans. Immun Ageing 13:27

    Article  PubMed  PubMed Central  Google Scholar 

  51. Lee YP, Chang CH, Liu HH et al (2016) Plasma zinc alpha2-glycoprotein levels correlate positively with frailty severity in female elders. Medicine (Baltimore) 95(35):e4753

    Article  CAS  Google Scholar 

  52. Chang CC et al (2017) Association between frailty and carotid intima media thickness and inflammatory marker in an elderly population. Geriatr Gerontol Int 17:2449–2454

    Article  PubMed  Google Scholar 

  53. Namioka N et al (2017) Oxidative stress and inflammation are associated with physical frailty in patients with Alzheimer’s disease. Geriatr Gerontol Int 17:913–918

    Article  PubMed  Google Scholar 

  54. Kucharska-Newton AM et al (2017) Operationalizing frailty in the atherosclerosis risk in communities study cohort. J Gerontol A Biol Sci Med Sci 72:382–388

    PubMed  Google Scholar 

  55. Hsu B et al (2019) Cross-sectional and longitudinal relationships between inflammatory biomarkers and frailty in community-dwelling older men: the concord health and ageing in men project. J Gerontol A Biol Sci Med Sci 74:835–841

    Article  CAS  PubMed  Google Scholar 

  56. Rizka A, Setiati S, Harimurti K et al (2018) Effect of alfacalcidol on inflammatory markers and T cell subsets in elderly with frailty syndrome: a double blind randomized controlled trial. Acta Med Indones 50:215–221

    PubMed  Google Scholar 

  57. Nascimento CMC et al (2018) Higher levels of tumor necrosis factor beta are associated with frailty in socially vulnerable community-dwelling older adults. BMC Geriatr 18:268

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Hou P, Xue H, Mao XE et al (2018) Inflammation markers are associated with frailty in elderly patients with coronary heart disease. Aging (Albany NY). 10:2636–2645

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Marcos-Perez D et al (2018) Frailty in older adults is associated with plasma concentrations of inflammatory mediators but not with lymphocyte subpopulations. Front Immunol 9:1056

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Navarro-Martinez R et al (2019) Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy. Urol Oncol 37:976–987

    Article  CAS  PubMed  Google Scholar 

  61. Alvarez-Sanchez N et al (2020) Homocysteine and C-reactive protein levels are associated with frailty in older Spaniards: The Toledo Study for Healthy Aging. J Gerontol A Biol Sci Med Sci 75:1488–1494

    Article  CAS  PubMed  Google Scholar 

  62. Castellana F et al (2021) Physical frailty, multimorbidity, and all-cause mortality in an older population from southern italy: results from the Salus in Apulia Study. J Am Med Dir Assoc 22:598–605

    Article  PubMed  Google Scholar 

  63. Cybularz M et al (2021) Frailty is associated with chronic inflammation and pro-inflammatory monocyte subpopulations. Exp Gerontol 149:111317

    Article  CAS  PubMed  Google Scholar 

  64. Barzilay JI, Blaum C, Moore T et al (2007) Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 167:635–641

    Article  PubMed  Google Scholar 

  65. Leng SX et al (2007) Inflammation and frailty in older women. J Am Geriatr Soc 55:864–871

    Article  PubMed  Google Scholar 

  66. Rønning B, Wyller TB, Seljeflot I et al (2010) Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patients. Age Ageing 39:758–761

    Article  PubMed  Google Scholar 

  67. Fernandez-Garrido J et al (2014) The value of neutrophil and lymphocyte count in frail older women. Exp Gerontol 54:35–41

    Article  PubMed  Google Scholar 

  68. Choe YR, Jeong JR, Kim YP (2020) Grip strength mediates the relationship between muscle mass and frailty. J Cachexia Sarcopenia Muscle 11:441–451

    Article  PubMed  Google Scholar 

  69. Nunez J et al (2020) Relation of low lymphocyte count to frailty and its usefulness as a prognostic biomarker in patients >65 years of age with acute coronary syndrome. Am J Cardiol 125:1033–1038

    Article  PubMed  Google Scholar 

  70. Marcos-Perez D et al (2020) Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis. Geroscience 42:1451–1473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Warny M et al (2020) Incidental lymphopenia and mortality: a prospective cohort study. CMAJ 192:E25–E33

    Article  PubMed  PubMed Central  Google Scholar 

  72. Walker KA et al (2019) Midlife systemic inflammation is associated with frailty in later life: The ARIC Study. J Gerontol A Biol Sci Med Sci 74:343–349

    Article  CAS  PubMed  Google Scholar 

  73. Scheller J et al (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878–888

    Article  CAS  PubMed  Google Scholar 

  74. Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245–270

    Article  CAS  PubMed  Google Scholar 

  75. Maggio M, Guralnik JM, Longo DL et al (2006) Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 61:575–584

    Article  PubMed  Google Scholar 

  76. Rosano C, Marsland AL, Gianaros PJ (2011) Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging. Aging Dis 3:16–33

    PubMed  PubMed Central  Google Scholar 

  77. Soysal P et al (2017) Oxidative stress and frailty: a systematic review and synthesis of the best evidence. Maturitas 99:66–72

    Article  CAS  PubMed  Google Scholar 

  78. Greiwe JS, Cheng B, Rubin DC et al (2001) Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J 15:475–482

    Article  CAS  PubMed  Google Scholar 

  79. Kane AE et al (2016) Animal models of frailty: current applications in clinical research. Clin Interv Aging 11:1519–1529

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Varadhan R et al (2014) Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. J Gerontol A Biol Sci Med Sci 69:165–173

    Article  CAS  PubMed  Google Scholar 

  81. Furtado GE, Uba Chupel M, Minuzzi L et al (2020) Exploring the potential of salivary and blood immune biomarkers to elucidate physical frailty in institutionalized older women. Exp Gerontol 129:110759

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

All authors have made substantive contributions to the manuscript.

Funding

This study was supported by the National Key Research and Development Program of China (2018YFC2002000).

Author information

Authors and Affiliations

Authors

Contributions

YSX and MMW contributed significantly to analysis and manuscript preparation; YSX, DC and XJ performed the data analyses and wrote the manuscript; ZFX helped perform the analysis with constructive discussions.

Corresponding author

Correspondence to ZhiFan Xiong.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

This article (ACER-D-21-00786: Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies) was based on previous published studies involved no humans and/or animals, and as such, this article have no ethical issue for human and animal rights.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

40520_2021_2022_MOESM1_ESM.pdf

Supplementary file1 Figure S1. Forest plot displaying standard mean difference (SMD) and 95% confidence intervals for WBC. (PDF 157 KB)

40520_2021_2022_MOESM2_ESM.pdf

Supplementary file2 Figure S2. Forest plot displaying standard mean difference (SMD) and 95% confidence intervals for IL-10. (PDF 65 KB)

Supplementary file3 Table S1. The PRISMA Checklist. (DOCX 18 KB)

Supplementary file4 Table S2. Assessment of methodological quality. (DOCX 27 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, Y., Wang, M., Chen, D. et al. Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies. Aging Clin Exp Res 34, 971–987 (2022). https://doi.org/10.1007/s40520-021-02022-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-021-02022-7

Keywords

Navigation